Changes in expression of P2X7 receptors in NOD mouse pancreas during the development of diabetes

Autoimmunity

Volumn 40, Issue 2, 2007, Pages 108-116

  Coutinho Silva, Robson ^a,b   Robson, Tim ^a   Beales, Philip ^c   Burnstock, Geoffrey ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Diabetes; Islet cells; NOD; P2X7 receptors

Indexed keywords

GLUCAGON; INSULIN; PURINE P2X7 RECEPTOR; SOMATOSTATIN; PURINE P2 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CELL DESTRUCTION; CELL MIGRATION; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITIC CELL; DIABETES MELLITUS; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOREACTIVITY; MACROPHAGE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL MOTION; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PHYSIOLOGY; SOMATOSTATIN CELL; SPLEEN;

ANIMALS; CELL MOVEMENT; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCAGON-SECRETING CELLS; IMMUNOHISTOCHEMISTRY; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; RECEPTORS, PURINERGIC P2; SOMATOSTATIN-SECRETING CELLS; SPLEEN;

EID: 33947199802     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930601118841     Document Type: Article

References (46)

1. Adorini, L., Gregori, S. and Harrison, LC (2002) Understanding autoimmune diabetes: Insights from mouse models. Trends Mol Med, 8, pp. 31-38.
2. Wicker, LS, Todd, JA and Peterson, LB (1995) Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol, 13, pp. 179-200.
3. Jansen, A., Homo-Delarche, F., Hooijkaas, H., Leenen, PJ, Dardenne, M. and Drexhage, HA (1994) Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta- cell destruction in NOD mice. Diabetes, 43, pp. 667-675.
4. Rosmalen, JG, Homo-Delarche, F., Durant, S., Kap, M., Leenen, PJ and Drexhage, HA (2000) Islet abnormalities associated with an early influx of dendritic cells and macrophages in NOD and NOD scid mice. Lab Invest, 80, pp. 769-777.
5. Rosmalen, JG, Martin, T., Dobbs, C., Voerman, JS, Drexhage, HA, Haskins, K. and Leenen, PJ (2000) Subsets of macrophages and dendritic cells in nonobese diabetic mouse pancreatic inflammatory infiltrates: Correlation with the development of diabetes. Lab Invest, 80, pp. 23-30.
6. 7). Science, 272, pp. 735-738.
7. 7 receptors by immunohistochemistry in rat stratified squamous epithelia. Cell Tissue Res, 296, pp. 599-605.
8. Gröschel-Stewart, U., Bardini, M., Robson, T. and Burnstock, G. (1999) P2X receptors in the rat duodenal villus. Cell Tissue Res, 297, pp. 111-117.
9. Greig, AVH, Linge, C., Healy, V., Lim, P., Clayton, E., Rustin, MH, McGrouther, DA and Burnstock, G. (2003) Expression of purinergic receptors in non-melanoma skin cancers and their functional roles in A431 cells. J Invest Dermatol, 121, pp. 315-327.
10. Coutinho-Silva, R., Alves, LA, de Carvalho, AC, Savino, W. and Persechini, PM (1996) Characterization of P2Z purinergic receptors on phagocytic cells of the thymic reticulum in culture. Biochim Biophys Acta, 1280, pp. 217-222.
11. 7 receptor-dependent apoptosis of dendritic cells. Am J Physiol, 276, pp. C1139-C1147.
12. 7 receptor characterized in murine dendritic cells: Role on the induction of apoptosis. Blood, 96, pp. 996-1005.
13. 7 receptor and polykarion formation. Mol Biol Cell, 11, pp. 3169-3176.
14. 7) receptors. Immunity, 7, pp. 433-444.
15. Stober, CB, Lammas, DA, Li, CM, Kumararatne, DS, Lightman, SL and McArdle, CA (2001) ATP-mediated killing of mycobacterium bovis bacille Calmette - Guerin within human macrophages is calcium dependent and associated with the acidification of mycobacteria-containing phagosomes. J Immunol, 166, pp. 6276-6286.
16. 7 receptor activity in macrophages infected with chlamydia psittaci. Am J Physiol, 280, pp. C81-C89.
17. Coutinho-Silva, R., Stahl, L., Raymond, M-N, Jungas, T., Verbeke, P., Burnstock, G., Darville, T. and Ojcius, DC (2003) Inhibition of chlamydial infectious activity due to P2XR-dependent phospholipase D activation. Immunity, 19, pp. 403-412.
18. 7 receptors. J Biol Chem, 276, pp. 125-132.
19. 7 receptors in neurodegeneration. Eur J Pharmacol, 447, pp. 261-269.
20. Virgilio, F Di (1995) The P2Z purinoceptor: An intriguing role in immunity, inflammation and cell death. Immunol Today, 16, pp. 524-528.
21. Virgilio, F Di, Chiozzi, P., Ferrari, D., Falzoni, S., Sanz, JM, Morelli, A., Torboli, M., Bolognesi, G. and Baricordi, OR (2001) Nucleotide receptors: An emerging family of regulatory molecules in blood cells. Blood, 97, pp. 587-600.
22. Sandler, S., Andersson, A. and Hellerstrom, C. (1987) Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology, 121, pp. 1424-1431.
23. Pavlovic, D., Andersen, NA, Mandrup-Poulsen, T. and Eizirik, DL (2000) Activation of extracellular signal-regulated kinase (ERK)1/2 contributes to cytokine-induced apoptosis in purified rat pancreatic β-cells. Eur Cytokine Netw, 11, pp. 267-274.
24. Ammendrup, A., Maillard, A., Nielsen, K., Aabenhus, AN, Serup, P., Dragsbaek, MO, Mandrup-Poulsen, T. and Bonny, C. (2000) The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic β-cells. Diabetes, 49, pp. 1468-1476.
25. Eizirik, DL and Mandrup-Poulsen, T. (2001) A choice of death-the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia, 44, pp. 2115-2133.
26. Hoorens, A., Stange, G., Pavlovic, D. and Pipeleers, D. (2001) Distinction between interleukin-1-induced necrosis and apoptosis of islet cells. Diabetes, 50, pp. 551-557.
27. Reddy, S., Bradley, J., Ginn, S., Pathipati, P. and Ross, JM (2003) Immunohistochemical study of caspase-3-expressing cells within the pancreas of non-obese diabetic mice during cyclophosphamide-accelerated diabetes. Histochem Cell Biol, 119, pp. 451-461.
28. Signore, A., Pozzilli, P., Gale, EA, Andreani, D. and Beverley, PC (1989) The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia, 32, pp. 282-289.
29. 7. Drug Dev Res, 47, pp. 189-195.
30. Llewellyn-Smith, IJ, Pilowsky, P. and Minson, JB (1993) The tungstate-stabilized tetramethylbenzidine reaction for light and electron microscopic immunocytochemistry and for revealing biocytin-filled neurons. J Neurosci Methods, 46, pp. 27-40.
31. Takamura, T., Ando, H., Nagai, Y., Yamashita, H., Nohara, E. and Kobayashi, K. (1999) Pioglitazone prevents mice from multiple low-dose streptozotocin-induced insulitis and diabetes. Diabetes Res Clin Pract, 44, pp. 107-114.
32. Hoglund, P., Mintern, J., Waltzinger, C., Heath, W., Benoist, C. and Mathis, D. (1999) Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med, 189, pp. 331-339.
33. Coutinho-Silva, R., Parsons, M., Robson, T. and Burnstock, G. (2001) Changes in expression of P2 receptors in rat and mouse pancreas during development and aging. Cell Tissue Res, 306, pp. 373-383.
34. Reddy, S., Pathipati, P., Bai, Y., Robinson, E. and Ross, JM (2005) Histopathological changes in insulin, glucagon and somatostatin cells in the islets of NOD mice during cyclophosphamide-accelerated diabetes: A combined immunohistochemical and histochemical study. J Mol Histol, 36, pp. 289-300.
35. Coutinho-Silva, R., Parsons, M., Robson, T., Lincoln, J. and Burnstock, G. (2003) P2X and P2Y purinoceptor expression in pancreas from streptozotocin-diabetic rats. Mol Cell Endocrinol, 204, pp. 141-154.
36. Riley, WJ, McConnell, TJ, Maclaren, NK, McLaughlin, JV and Taylor, G. (1981) The diabetogenic effects of streptozotocin in mice are prolonged and inversely related to age. Diabetes, 30, pp. 718-723.
37. Kim, BM, Han, YM, Shin, YJ, Min, BH and Park, IS (2001) Clusterin expression during regeneration of pancreatic islet cells in streptozotocin-induced diabetic rats. Diabetologia, 44, pp. 2192-2202.
38. Fraser, RB, Rowden, G., Colp, P. and Wright, JR (1997) Immunophenotyping of insulitis in control and essential fatty acid deficient mice treated with multiple low-dose streptozotocin. Diabetologia, 40, pp. 1263-1268.
39. 7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-γ in the human THP-1 monocytic cell line. J Immunol, 157, pp. 5627-5637.
40. 7 purinergic receptor: Characterization and possible participation in antigen presentation. J Immunol, 163, pp. 1958-1965.
41. 7 nucleotide receptor function in human monocytes by extracellular ions and receptor density. Am J Physiol Cell Physiol, 280, pp. C943-C953.
42. Novak, I. (2003) ATP as a signaling molecule: The exocrine focus. News Physiol Sci, 18, pp. 12-17.
43. Fernandez-Alvarez, J., Hillaire-Buys, D., Loubatières-Mariani, MM, Gomis, R. and Petit, P. (2001) P2 receptor agonists stimulate insulin release from human pancreatic islets. Pancreas, 22, pp. 69-71.
44. Chevassus, H., Roig, A., Belloc, C., Lajoix, AD, Broca, C., Manteghetti, M. and Petit, P. (2002) P2Y receptor activation enhances insulin release from pancreatic β-cells by triggering the cyclic AMP/protein kinase a pathway. Naunyn Schmiedeberg's Arch Pharmacol, 366, pp. 464-469.
45. 7 receptor: A candidate susceptibility gene for NOD diabetes. Diabetes, 53, pp. 2012-2017.
46. O'Brien, BA, Huang, Y., Geng, X., Dutz, JP and Finegood, DT (2002) Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes, 51, pp. 2481-2488.